Trump’s drug ad price transparency contains huge loophole, researchers identify By Wayne Drash, CNN 4 minute read Updated 6:28 PM EST, Tue January 22, 2019 ...

Eric Edwards is co-founder and chief executive officer of Phlow, a public benefit pharmaceutical corporation. He previously co-founded pharmaceutical company Kaléo, where, among other roles, he ...

Deflazacort, a newly FDA-approved drug for Duchenne muscular dystrophy, has an $89,000-a-year price tag. It has been put on hold because of an uproar over drug prices.

As healthcare and pharmaceutical brands have embraced digital marketing initiatives during the pandemic, transparency has been essential for marketers in the industry.

The hot anti-inflammatory drug has been costing employer plans about $78,000 per 1,000 covered lives. A patient’s genes may affect which GLP-1 obesity drugs work best, researchers say ...

New PBM players banking on drug pricing transparency for success. Newcomers aim to do what larger PBMs like CVS and United HealthCare have been reluctant to do, and what legislators have failed to do.

Last week, Senators Durbin (D - Illinois) and Grassley (R - Iowa) attempted to advance the Drug-Price Transparency in Communications Act through unanimous consent, but objections from Senator ...

Oregon suspends a portion of its drug transparency law found to be unconstitutional. By Ed Silverman Feb. 23, 2024. Reprints. Adobe.

A bill introduced Wednesday by Democratic Sen. Ron Wyden is designed to shed some light on one of the drug industry's biggest middlemen. Pharmacy benefit managers are the companies responsible for ...

The bill is strongly opposed by the pharmaceutical industry, partially out of fear that SB 17 could become a national model and the first major step toward price controls ...

Deflazacort, a newly FDA-approved drug for Duchenne muscular dystrophy, has an $89,000-a-year price tag. It has been put on hold because of an uproar over drug prices.